What this trial studies
Women typically enter menopause between the ages of 40 and 47, and they spend approximately one-third of their lives in this phase. During menopause, many experience hot flashes due to decreased estrogen levels, along with vasomotor changes such as altered heart rhythms and sleep disturbances. These issues may accompany or occur independently of hot flashes. Additionally, psychological changes can arise, including tension, sudden mood swings, anxiety, stress, and depression.
Conditions in scope
- Menopause
- Menopause Related Conditions
Interventions
- progressive relaxation exercises (Behavioral) — Participants with menopausal symptoms received progressive relaxation exercise training, led by the responsible researcher who assigned them to the experimental group.
Who can join
Women only · Ages 45 Years to 65 Years · Accepts healthy volunteers.
Inclusion criteria
- Being a woman between the ages of 45-65
- Being able to read and understand Turkish
- Being at least a primary school graduate
- Not having menstruation for a year
Exclusion criteria
- Having a disability in maintaining communication (such as hearing and speaking)
- Having entered early menopause (no menstruation) through surgery or natural means,
- Being on hormone therapy
- Filling out forms incompletely
Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.
Where it’s happening
| City | State / Region | Facility | Site status |
|---|---|---|---|
| Nilufer | Bursa | Bursa Uludağ Üniversitesi | Unknown |
| Bursa | Bursa Uludag University | Unknown |
Status & timeline
- Overall status: Enrolling by invitation
- Study type: Interventional
- Phase: N/A
- Start date: 2025-04-30
- Primary completion: 2025-09-30
- Last update posted: 2025-07-25
- First posted: 2025-07-25
Sponsor & contact
Lead sponsor: Aydin Adnan Menderes University (Other)
Collaborators: Uludag University
For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.
Outcome measures
Primary outcomes
- Personal information form before intervention (Day 1 (During recruitment))
Evaluation of women using personal information. This tool includes questions on women's sociodemographic characteristics - Before intervention, menopausal symptoms (Day 1 (during recruitment))
Evaluation of menopausal symptoms with Menopause Rating Scale (MRS). It is a Likert-type scale consisting of 11 items, including menopausal complaints. For each item, there are options of "0= None", "1= Mild", "2= Moderate", "3= Severe", and "4= Very severe". The lowest possible score is 0, the highest score is 44. An increase in the total score obtained from the… - Before intervention, Individual work performance (Day 1 (During recruitment))
Before intervention, participants are evaluated with the "Individual Work Performance Questionnaire"The scale was designed to measure job performance perception. It consists of 18 Likert-type items. A high score on the scale indicates that job performance perception has increased.
Related ClearedRx care
If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.
Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT07085078 before contacting a site.
ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.